ST-617

N/A

Report date: 2023/11/08 18:10:24

Base Information

Drug NameST-617
Drug Alias NameST-617
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsStomatitisHead and Neck Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSupportive Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesSupportive Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsStomatitisHead and Neck Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A